Cited by 174Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRadiation Therapy and Dosimetry

The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index.

Hybrid nanoparticles for combination therapy of cancer

Open access

He, Chunbai, Lu, Jianqin, Lin, Wenbin·2015·Journal of Controlled Release

DOI 10.1016/j.jconrel.2015.09.029PMC PMC4656047

Open this paper in CoChat — free account

Abstract

Nanoparticle anticancer drug delivery enhances therapeutic efficacies and reduces side effects by improving pharmacokinetics and biodistributions of the drug payloads in animal models. Despite promising preclinical efficacy results, monotherapy nanomedicines have failed to produce enhanced response rates over conventional chemotherapy in human clinical trials. The discrepancy between preclinical data and clinical outcomes is believed to result from the less pronounced enhanced permeability and retention (EPR) effect in and the heterogeneity of human tumors as well as the intrinsic/acquired drug resistance to monotherapy over the treatment course. To address these issues, recent efforts have been devoted to developing nanocarriers that can efficiently deliver multiple therapeutics with controlled release properties and increased tumor deposition. In ideal scenarios, the drug or therapeutic modality combinations have different mechanisms of action to afford synergistic effects. In this review, we summarize recent progress in designing hybrid nanoparticles for the co-delivery of combination therapies, including multiple chemotherapeutics, chemotherapeutics and biologics, chemotherapeutics and photodynamic therapy, and chemotherapeutics and radiotherapy. The in vitro and in vivo anticancer effects are also discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2015.09.029

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,906
Metal–Organic Frameworks for Separations
Li, J.-R., Sculley, J., & Zhou, H.-C. (2012) · Chemical Reviews · doi:10.1021/cr200190s · Cited by 6,323
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
Huang, X., El‐Sayed, I. H., Qian, W. P., & El‐Sayed, M. A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057254a · Cited by 5,442
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Hydrogen Storage in Microporous Metal-Organic Frameworks
Rosi, N. L., Eckert, J., Eddaoudi, M., Vodak, D. T., Kim, J., O’Keeffe, M., & Yaghi, O. M. (2003) · Science · doi:10.1126/science.1083440 · Cited by 4,850
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,775
Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging
Horcajada, P., Chalati, T., Serre, C., Gillet, B., Sebrié, C., Baâti, T., Eubank, J. F., Heurtaux, D., Clayette, P., Rogez‐Kreuz, C., et al. (2009) · Nature Materials · doi:10.1038/nmat2608 · Cited by 4,270
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Luminescent metal–organic frameworks for chemical sensing and explosive detection
Hu, Z., Deibert, B. J., & Li, J. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00010b · Cited by 4,168

Show all 108 references

Sorted by citations

Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B. C., Huang, P., & Chen, X. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,813
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Tang, W., Fan, W., Lau, J., Deng, L., Shen, Z., & Chen, X. S. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00805a · Cited by 610
Aggregation-Induced Emission (AIE), Life and Health
Wang, H., Li, Q., Alam, P., Bai, H., Bhalla, V., Bryce, M. R., Cao, M., Chen, C., Chen, S., Chen, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c03925 · Cited by 404
Intracellularly Acid-Switchable Multifunctional Micelles for Combinational Photo/Chemotherapy of the Drug-Resistant Tumor
Wang, T., Wang, D., Yu, H., Wang, M., Liu, J., Feng, B., Zhou, F., Yin, Q., Zhang, Z., Huang, Y., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07706 · Cited by 294
Gold nanoparticles in combinatorial cancer therapy strategies
Beik, J., Khateri, M., Khosravi, Z., Kamrava, S. K., Kooranifar, S., Ghaznavi, H., & Shakeri‐Zadeh, A. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.02.025 · Cited by 235
Enhancement of EPR Effect for Passive Tumor Targeting: Current Status and Future Perspectives
Vagena, I.-A., Malapani, C., Gatou, Μ.-A., Lаgopati, N., & Pavlatou, E. A. (2025) · Applied Sciences · doi:10.3390/app15063189 · Cited by 252
MOF materials as therapeutic agents, drug carriers, imaging agents and biosensors in cancer biomedicine: Recent advances and perspectives
Bieniek, A., Terzyk, A. P., Wiśniewski, M., Roszek, K., Kowalczyk, P., Sarkisov, L., Keskın, S., & Kaneko, K. (2020) · Progress in Materials Science · doi:10.1016/j.pmatsci.2020.100743 · Cited by 222
Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy
Liu, Y., Qiao, L., Zhang, S., Wan, G., Chen, B., Zhou, P., Zhang, N., & Wang, Y. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.010 · Cited by 219
Polymer-hybrid nanoparticles: Current advances in biomedical applications
Soares, D. C. F., Domingues, S. C., Viana, D. B., & Tebaldi, M. L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110695 · Cited by 216
Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review
He, Z., Zhang, Y., & Feng, N. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110298 · Cited by 217
Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy
Goel, S., Ferreira, C. A., Chen, F., Ellison, P. A., Siamof, C. M., Barnhart, T. E., & Cai, W. (2017) · Advanced Materials · doi:10.1002/adma.201704367 · Cited by 208
Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer
Castillo, R. R., Colilla, M., & Vallet‐Regí, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1211637 · Cited by 181
A thermo-responsive alginate nanogel platform co-loaded with gold nanoparticles and cisplatin for combined cancer chemo-photothermal therapy
Mirrahimi, M., Abed, Z., Beik, J., Shiri, I., Dezfuli, A. S., Mahabadi, V. P., Kamrava, S. K., Ghaznavi, H., & Shakeri‐Zadeh, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.005 · Cited by 166
Combination antitumor therapy with targeted dual-nanomedicines
Dai, W., Wang, X., Song, G., Liu, T., He, B., Zhang, H., Wang, X., & Zhang, Q. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.001 · Cited by 139
Nanomedicine in treatment of breast cancer – A challenge to conventional therapy
Afzal, M., Zafar, A., Alharbi, K. S., Alruwaili, N. K., Al-Abbasi, F. A., Almalki, A. A., Kazmi, I. A., Kumar, V., Kamal, M. A., Nadeem, M. S., et al. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.016 · Cited by 125
Iron Oxide Nanoparticles: Innovative Tool in Cancer Diagnosis and Therapy
Martinková, P., Brtnický, M., Kynický, J., & Pohanka, M. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700932 · Cited by 126
State-of-the-art iron-based nanozymes for biocatalytic tumor therapy
Li, M., Zhang, H., Hou, Y., Wang, X., Xue, C., Li, W., Cai, K., Zhao, Y., & Luo, Z. Y. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00577c · Cited by 122
Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
Liu, J., Cheng, H., Han, L., Qiang, Z., Zhang, X., Gao, W., Zhao, K., & Song, Y. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s172199 · Cited by 119
Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems
Kamal, M. M., Akter, S., Lin, C.-N., & Nazzal, S. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01225-2 · Cited by 115
Mutually Synergistic Nanoparticles for Effective Thermo‐Molecularly Targeted Therapy
Luo, H., Wang, Q., Deng, Y., Yang, T., Ke, H., Yang, H., He, H., Guo, Z., Yu, D. S., Wu, H., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201702834 · Cited by 114
Nanoparticles for radiooncology: Mission, vision, challenges
Kunz‐Schughart, L. A., Dubrovska, A., Peitzsch, C., Ewe, A., Aigner, A. M., Schellenburg, S., Muders, M. H., Hampel, S., Cirillo, G., Iemma, F., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.010 · Cited by 110
Two-dimensional metal-organic-framework as a unique theranostic nano-platform for nuclear imaging and chemo-photodynamic cancer therapy
Zhu, W., Yang, Y. P., Jin, Q., Chao, Y., Tian, L., Liu, J., Dong, Z., & Liu, Z. (2018) · Nano Research · doi:10.1007/s12274-018-2242-2 · Cited by 105
Nanoscale metal-organic frameworks and coordination polymers as theranostic platforms for cancer treatment
Zhu, W., Zhao, J., Chen, Q., & Liu, Z. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.07.006 · Cited by 106
Nanoparticles in radiation oncology: From bench-side to bedside
Rancoule, C., Magné, N., Vallard, A., Guy, J., Rodriguez‐Lafrasse, C., Deutsch, É., & Chargari, C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.011 · Cited by 96
Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin
Guo, S., Zhang, Y., Wu, Z., Zhang, L., He, D., Li, X., & Wang, Z. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109225 · Cited by 88
Strategies for optimizing the delivery to tumors of macrocyclic photosensitizers used in photodynamic therapy (PDT)
Moret, F., & Reddi, E. (2017) · Journal of Porphyrins and Phthalocyanines · doi:10.1142/s1088424617300014 · Cited by 81
Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
Kiaie, S. H., Salehi‐Shadkami, H., Sanaei, M., Azizi, M., Barough, M. S., Nasr, M. S., & Sheibani, M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02083-y · Cited by 83
Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy
Shen, S., Liu, M., Li, T., Lin, S., & Mo, R. (2017) · Biomaterials Science · doi:10.1039/c7bm00297a · Cited by 77
Self-Assembled Oxaliplatin(IV) Prodrug–Porphyrin Conjugate for Combinational Photodynamic Therapy and Chemotherapy
Lim, W. Q., Yang, G., Phua, S. Z. F., Chen, H., & Zhao, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b04557 · Cited by 75
All-in-One Alkaline Phosphatase-Response Aggregation-Induced Emission Probe for Cancer Discriminative Imaging and Combinational Chemodynamic–Photodynamic Therapy
Xiong, L., Yang, L., Geng, J., Tang, B. Z., & He, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c03879 · Cited by 73
Emerging Antineoplastic Biogenic Gold Nanomaterials for Breast Cancer Therapeutics: A Systematic Review
Saravanan, M., Vahidi, H., Medina-Cruz, D., Vernet-Crua, A., Mostafavi, E., Stelmach, R., Webster, T. J., Mahjoub, M. A., Rashedi, M., & Barabadi, H. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s240293 · Cited by 77
RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma
Wang, C., Su, L., Wu, C., Wu, J., Zhu, C., & Yuan, G. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1185435 · Cited by 69
Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model
Moreno, V., Álvarez, E., Izquierdo‐Barba, I., Baeza, A., Serrano‐López, J., & Vallet‐Regí, M. (2020) · Advanced Materials Interfaces · doi:10.1002/admi.201901942 · Cited by 65
Advances in cancer theranostics using organic-inorganic hybrid nanotechnology
Chen, G., Qian, Y., Zhang, H., Ullah, A., He, X., Zhou, Z., Fenniri, H., & Shen, J. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101003 · Cited by 63
Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting
Bouchoucha, M., Béliveau, É., Kleitz, F., Calon, F., & Fortin, M. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01385j · Cited by 65
Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications
Liu, J., Liu, T., Pan, J., Liu, S., & Lu, G. Q. (2018) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-060817-084225 · Cited by 63
Nanodelivery of natural isothiocyanates as a cancer therapeutic
Wang, Q., & Bao, Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.044 · Cited by 60
Dual Stimuli-Responsive Hybrid Polymeric Nanoparticles Self-Assembled from POSS-Based Starlike Copolymer-Drug Conjugates for Efficient Intracellular Delivery of Hydrophobic Drugs
Yang, Q., Li, L., Sun, W., Zhou, Z., & Huang, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02403 · Cited by 62
Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming
Fang, J., Hsueh, Y., Soto, J., Sun, W., Wang, J., Gu, Z., Khademhosseini, A., & Li, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b04837 · Cited by 61
Biotin Decorated Gold Nanoparticles for Targeted Delivery of a Smart-Linked Anticancer Active Copper Complex: In Vitro and In Vivo Studies
Pramanik, A., SiddikUzzaman, B. S. P., Palanimuthu, D., Somasundaram, K., & Samuelson, A. G. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00537 · Cited by 60
Light-triggered dual-modality drug release of self-assembled prodrug-nanoparticles for synergistic photodynamic and hypoxia-activated therapy
Zhao, D., Tao, W., Li, S., Li, L., Sun, Y., Li, G., Wang, G., Wang, Y., Lin, B., Luo, C., et al. (2020) · Nanoscale Horizons · doi:10.1039/d0nh00034e · Cited by 58
A bio-responsive 6-mercaptopurine/doxorubicin based “Click Chemistry” polymeric prodrug for cancer therapy
Liao, J., Peng, H., Wei, X., Song, Y., Liu, C., Li, D., Yin, Y., Xiong, X., Zheng, H. S., & Wang, Q. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110461 · Cited by 56
Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance
Huang, C., Azizi, P., Vazirzadeh, M., Zarch, S. M. A., Aghaei-Zarch, F., Ghanavi, J., & Farnia, P. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04510-y · Cited by 56
Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy
Theivendren, P., Kunjiappan, S., Pavadai, P., Ravi, K., Murugavel, A., Dayalan, A., & Kumar, A. S. K. (2024) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.4c00062 · Cited by 65
Co-Delivery of 2-Dg and V9302 Via a Prodrug Micellar Formulation for Synergistic Targeting of Metabolism in Cancer
Luo, Z., Xu, J., Sun, J., Huang, H., Zhang, Z., Ma, W., Wan, Z., Liu, Y., Pardeshi, A., & Li, S. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.01.019 · Cited by 52
Bacteria-Assisted Transport of Nanomaterials to Improve Drug Delivery in Cancer Therapy
Jiménez‐Jiménez, C., Moreno, V., & Vallet‐Regí, M. (2022) · Nanomaterials · doi:10.3390/nano12020288 · Cited by 57
Magnetic nanoscale metal–organic frameworks for magnetically aided drug delivery and photodynamic therapy
Sharma, S., Sethi, K., & Roy, I. (2017) · New Journal of Chemistry · doi:10.1039/c7nj02032e · Cited by 49
Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy
Chen, J., Yang, X., Huang, L., Lai, H., Gan, C., & Luo, X. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1477856 · Cited by 48
Synthesis, characterization and biocompatibility of polypyrrole/Cu(II) metal-organic framework nanocomposites
Neisi, Z., Ansari‐Asl, Z., Jafarinejad‐Farsangi, S., Tarzi, M. E., Sedaghat, T., & Nobakht, V. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.03.032 · Cited by 47
High-Performance Dual Combination Therapy for Cancer Treatment with Hybrid Membrane-Camouflaged Mesoporous Silica Gold Nanorods
Li, H., Peng, Q., Yang, L., Lin, Y., Chen, S., Qin, Y., Li, S., Yu, X., & Zhang, L. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c18287 · Cited by 47
Nanotechnology in Drug Discovery and Development
Gutiérrez, L., Stepien, G., Gutiérrez, L., Pérez-Hernández, M., Pardo, J., Pardo, J., Grazú, V., & de la Fuente, J. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12292-9 · Cited by 51
Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges
Li, W., Little, N., Park, J., Foster, C. A., Chen, J., & Lu, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00455 · Cited by 46
Self-citation
Bioinspired Multivalent Peptide Nanotubes for Sialic Acid Targeting and Imaging‐Guided Treatment of Metastatic Melanoma
Li, L., Xu, Z., Hu, X., Lai, Y., Xu, J., Hou, B., Wang, Y., Yu, H., Tian, Y., & Zhang, W. (2019) · Small · doi:10.1002/smll.201900157 · Cited by 43
Nanoparticles for Cancer Immunotherapy: Innovations and Challenges
Fallatah, M., Alradwan, I. A., Fayez, N. A., Aodah, A. H., Alkhrayef, M. N., Majrashi, M. A., & Jamous, Y. F. (2025) · Pharmaceuticals · doi:10.3390/ph18081086 · Cited by 45
In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin
Alvarez-Berríos, M. P., & Vivero-Escoto, J. L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s118196 · Cited by 42
Natural Product-Based Hybrids as Potential Candidates for the Treatment of Cancer: Focus on Curcumin and Resveratrol
Micale, N., Molonia, M. S., Citarella, A., Cimino, F., Saija, A., Cristani, M., & Speciale, A. (2021) · Molecules · doi:10.3390/molecules26154665 · Cited by 42
Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery
Zhang, Y., Zhang, P., & Zhu, T. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.158 · Cited by 40
Multifunctional nanoplatform for enhanced photodynamic cancer therapy and magnetic resonance imaging
Hao, Y., Zhang, B., Zheng, C., Niu, M., Guo, H., Zhang, H., Chang, J., Zhang, Z., Wang, L., & Zhang, Y. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.10.039 · Cited by 39
Pillararene-Based Supramolecular Polymers for Cancer Therapy
Yan, M., & Zhou, J. (2023) · Molecules · doi:10.3390/molecules28031470 · Cited by 36
Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology – A new chance for causative therapy?
Groner, J., Göpferich, A. M., & Breunig, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.034 · Cited by 34
Recent Advances in Tetrakis (4‐Carboxyphenyl) Porphyrin‐Based Nanocomposites for Tumor Therapy
Xie, Y., Wang, M., Sun, Q., Wang, D., & Li, C. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200136 · Cited by 33
Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic
Nair, R., Paul, P., Maji, I., Gupta, U., Mahajan, S., Aalhate, M., Guru, S. K., & Singh, P. K. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121644 · Cited by 33
Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation
Faderin, E., Iorkula, T. H., Aworinde, O. R., Awoyemi, R. F., Awoyemi, C. T., Acheampong, E., Agyemang, P., Onaiwu, G. E., & Ifijen, I. H. (2025) · Medical Oncology · doi:10.1007/s12032-024-02598-w · Cited by 35
Tumor cell membrane-derived nano-Trojan horses encapsulating phototherapy and chemotherapy are accepted by homologous tumor cells
Zhang, Y., He, Z., Li, Y., Xia, Q., Li, Z., Hou, X., & Feng, N. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111670 · Cited by 33
Red light active Pt( iv )–BODIPY prodrug as a mitochondria and endoplasmic reticulum targeted chemo-PDT agent
Bera, A., Gautam, S., Sahoo, S., Pal, A. K., Kondaiah, P., & Chakravarty, A. R. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00225f · Cited by 31
Core-satellite porphyrinic MOF@CuS nanoconstructs for combined chemodynamic/photodynamic/photothermal therapy
Wei, G., Lian, X., Qin, X., Zhao, Y., Cai, L., Chen, Q., Zou, J., & Tian, J. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.111302 · Cited by 31
Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation
Liu, Y., Ma, Y., Zhang, W., Yang, Z., Liang, D.-S., Wu, Z., & Qi, X. (2017) · Oncotarget · doi:10.18632/oncotarget.17205 · Cited by 29
Co-delivery of doxorubicin and pheophorbide A by pluronic F127 micelles for chemo-photodynamic combination therapy of melanoma
Zhang, C., Zhang, J., Qin, Y., Song, H., Huang, P., Wang, W., Wang, C., Li, C., Wang, Y., & Kong, D. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03179c · Cited by 29
Co-Encapsulation of Chlorin e6 and Chemotherapeutic Drugs in a PEGylated Liposome Enhance the Efficacy of Tumor Treatment: Pharmacokinetics and Therapeutic Efficacy
Peng, P., Hong, R., Tsai, T., & Chen, C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110617 · Cited by 29
An NIR-activated polymeric nanoplatform with ROS- and temperature-sensitivity for combined photothermal therapy and chemotherapy of pancreatic cancer
Zhan, X., Nie, X., Gao, F., Zhang, C., You, Y., & Yu, Y. (2020) · Biomaterials Science · doi:10.1039/d0bm01324b · Cited by 28
Nanoscale metal–organic frameworks as photosensitizers and nanocarriers in photodynamic therapy
Matlou, G. G., & Abrahamse, H. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.971747 · Cited by 31
Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy
Meng, F., Han, N., & Yeo, Y. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1218464 · Cited by 28
Hybrid Nano-carriers for Potential Drug Delivery
Madni, A., Tahir, N., Rehman, M., Raza, A., Mahmood, M. A., Khan, M. I., & Kashif, P. M. (2017) · InTech eBooks · doi:10.5772/66466 · Cited by 28
Easy on-demand self-assembly of lateral nanodimensional hybrid graphene oxide flakes for near-infrared-induced chemothermal therapy
Thapa, R. K., Byeon, J. H., Ku, S., Yong, C. S., & Kim, J. O. (2017) · NPG Asia Materials · doi:10.1038/am.2017.141 · Cited by 27
Toxicity assessment of ZnO-decorated Au nanoparticles in the Mediterranean clam Ruditapes decussatus
Sellami, B., Mezni, A., Khazri, A., Bouzidi, I., Saidani, W., Sheehan, D., & Beyrem, H. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.04.005 · Cited by 26
The potential for clinical translation of antibody-targeted nanoparticles in the treatment of acute myeloid leukaemia
Guo, J., Luan, X., Cong, Z., Sun, Y., Wang, L., McKenna, S. L., Cahill, M. R., & O’Driscoll, C. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.024 · Cited by 26
DNA Nanotechnology for Multimodal Synergistic Theranostics
Yu, K., Qiao, Z., Song, W., & Bi, S. (2021) · Journal of Analysis and Testing · doi:10.1007/s41664-021-00182-z · Cited by 25
Recent Advances on Affibody- and DARPin-Conjugated Nanomaterials in Cancer Therapy
Gabriele, F., Palerma, M., Ippoliti, R., Angelucci, F., Pitari, G., & Ardini, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108680 · Cited by 25
A method to selectively internalise submicrometer boron carbide particles into cancer cells using surface transferrin conjugation for developing a new boron neutron capture therapy agent
Tsuji, T., Yoshitomi, H., Ishikawa, Y., Koshizaki, N., Suzuki, M., & Usukura, J. (2019) · Journal of Experimental Nanoscience · doi:10.1080/17458080.2019.1692178 · Cited by 24
Combination photodynamic therapy of human breast cancer using salicylic acid and methylene blue
Hosseinzadeh, R., Khorsandi, K., & Jahanshiri, M. (2017) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2017.05.008 · Cited by 23
Polyunsaturated fatty acid-based targeted nanotherapeutics to enhance the therapeutic efficacy of docetaxel
Ramasamy, T., Sundaramoorthy, P., Ruttala, H., Choi, Y., Shin, W. H., Jeong, J.-H., Ku, S., Choi, H.-G., Kim, H.-M., Yong, C., et al. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1373163 · Cited by 23
Fe3O4@Au core–shell hybrid nanocomposite for MRI-guided magnetic targeted photo-chemotherapy
Khani, T., Alamzadeh, Z., Sarikhani, A., Mousavi, M., Mirrahimi, M., Tabei, M., Irajirad, R., Abed, Z., & Beik, J. (2022) · Lasers in Medical Science · doi:10.1007/s10103-021-03486-9 · Cited by 25
Natural Salep/PEGylated Chitosan Double Layer toward a More Sustainable pH-Responsive Magnetite Nanocarrier for Targeted Delivery of DOX and Hyperthermia Application
Zohreh, N., Alipour, S., Hosseini, S. H., Xaba, M. S., Meijboom, R., Fasihi‐Ramandi, M., Gholipour, N., & Akhlaghi, M. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b02076 · Cited by 22
Surface-modified nanotherapeutics targeting atherosclerosis
Li, W., Gonzalez, K. M., Chung, J., Kim, M., & Lu, J. (2022) · Biomaterials Science · doi:10.1039/d2bm00660j · Cited by 22
Self-citation
Brassica‐derived isothiocyanates as anticancer therapeutic agents and their nanodelivery
Rizwan, D., & Masoodi, F. A. (2023) · Phytotherapy Research · doi:10.1002/ptr.8042 · Cited by 22
Core-shell lipid polymer nanoparticles for combined chemo and gene therapy of childhood head and neck cancers
Zhang, T., Ma, J., Li, C., Lin, K. Y., Lou, F., Jiang, H., Gao, Y., Yang, Y., Ming, C., & Ruan, B. (2017) · Oncology Reports · doi:10.3892/or.2017.5365 · Cited by 22
Nanoparticles for tumor targeting
Jiang, T., Jin, K., Liu, X., & Pang, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101914-6.00008-9 · Cited by 22
Advances in Hybrid Vesicular-based Drug Delivery Systems: Improved Biocompatibility, Targeting, Therapeutic Efficacy and Pharmacokinetics of Anticancer Drugs
Setia, A., Sahu, R. K., Ray, S., Widyowati, R., Ekasari, W., & Saraf, S. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220627110049 · Cited by 21
Dually responsive gold–iron oxide heterodimers: merging stimuli-responsive surface properties with intrinsic inorganic material features
Kakwere, H., Materia, M. E., Curcio, A., Prato, M., Sathya, A., Nitti, S., & Pellegrino, T. (2018) · Nanoscale · doi:10.1039/c7nr06726g · Cited by 21
Surface‐functionalised hybrid nanoparticles for targeted treatment of cancer
Tariq, H., & Bokhari, S. A. I. (2020) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2020.0073 · Cited by 18
Evaluation of the penetration process of fluorescent collagenase nanocapsules in a 3D collagen gel
Moreno, V., Baeza, A., & Vallet‐Regí, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.022 · Cited by 18
Herbal based nanoparticles as a possible and potential treatment of cancer: a review
Yadav, R., Chawra, H. S., Dubey, G., Alam, M. S., Kumar, V., Sharma, P., Upadhyay, N. K., & Yadav, T. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002285 · Cited by 20
Carbon dots meet artificial intelligence: applications in biomedical engineering
Guo, Y., Liu, Y., Yang, J., Wu, Y., Lian, H., Tang, X., Li, C., Cui, W., & Guo, Z. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00593k · Cited by 17
Cancer and pulmonary hypertension: Learning lessons and real-life interplay
Pullamsetti, S. S., Nayakanti, S. R., Chelladurai, P., Mamazhakypov, A., Mansouri, S., Savai, R., & Seeger, W. (2020) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2020.10 · Cited by 15
Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
Piórecka, K., Kurjata, J., & Stańczyk, W. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179264 · Cited by 15
Dual-Function Hybrid Nanoparticles with Gene Silencing and Anti-Inflammatory Effects
Fihurka, O., Sava, V., & Sanchez‐Ramos, J. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0458 · Cited by 15
Photoacoustic contrast agents: a review focusing on image-guided therapy
Yang, X., Jiang, Z., Dai, J., Fu, Q., & Pan, S. (2025) · Nanoscale Horizons · doi:10.1039/d4nh00395k · Cited by 14
Multifunctional nanophotonic photoacoustic biosensors: a new era in molecular imaging–guided deep-tissue cancer monitoring
Taha, B. A., Sulaiman, G. M., Addie, A. J., Khalil, K., Ahmed, E. M., Chaudhary, V., & Arsad, N. (2025) · Methods · doi:10.1016/j.ymeth.2025.06.005 · Cited by 16
Structure-Based Evaluation of Hybrid Lipid–Polymer Nanoparticles: The Role of the Polymeric Guest
Chountoulesi, M., Pippa, Ν., Foryś, A., Trzebicka, B., & Pispas, S. (2024) · Polymers · doi:10.3390/polym16020290 · Cited by 14

Authors: He, C., Lu, J., & Lin, W.
Affiliations: University of Chicago (US)
Corresponding author: Lin, Wenbin
ORCID: Lu, Jianqin
Lin, Wenbin
Venue: Journal of Controlled Release
Publisher: Elsevier BV
Published: 2015-12
Volume: 219
Pages: 224-236
ISSN: 0168-3659 (ISSN-L)
DOI: 10.1016/j.jconrel.2015.09.029
PMC: PMC4656047
OpenAlex: W1770290865
Cited by: 174
References: 108
Citations by year: 2026: 16 · 2025: 28 · 2024: 19 · 2023: 13 · 2022: 13 · 2021: 13 · 2020: 16 · 2019: 15 · 2018: 9 · 2017: 20 · 2016: 12
FWCI: 4.95
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Controlled Release (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: NIH (U01-CA151455)
University of Chicago Medicine Comprehensive Cancer Center (P30 CA014599)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
Keywords: hybrid nanostructures, combination cancer therapy, co-delivery, nanocarriers, drug resistance, enhanced permeability and retention effect, tumor heterogeneity, photodynamic therapy, radiotherapy, chemotherapeutics, biologics, controlled release, synergistic drug delivery
MeSH terms: Animals, Antineoplastic Agents, Drug Combinations, Ferric Compounds, Gold, Humans, Neoplasms, Organometallic Compounds, Polymers, Drug Delivery Systems, Organosilicon Compounds, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hybrid nanoparticles for combination therapy of cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks